The r/Esthetics post "Is LED light suitable for all skin??" comes from an esthetician of ten years, and it is the kind of question that is more useful than most of the enthusiastic content written about LED devices. She read that LED can worsen melasma. She is pregnant, used an LED mask at home consistently for a week, and noticed a large brown patch on her forehead. She used to place every client under a LED dome at the end of facials and stopped mostly because of time — and now she is questioning the modality itself. She is not asking whether LED does anything. She is asking whether it is safe for everyone, which is the question a treatment room actually needs answered.
The reason the question keeps coming up is that LED has been marketed as the benign device: no downtime, no pain, no consumables, nothing to go wrong. That framing is what makes it easy to stop screening, and screening is exactly what a modality with a plausible link to pigment changes requires. The honest answer is that LED is among the most forgiving professional treatments available, and forgiving is not the same as suitable for all skin, all medications, and all conditions.
Where the risk actually sits
The mechanism behind the melasma concern is not mysterious. Light therapy delivers energy into the skin, and any treatment that does so can interact with pigmentation. Melasma is a pigmentation disorder with a strong tendency to respond to triggers that include heat and light exposure, which is why practitioners who treat it carefully are already cautious about layering heat-based treatments over a melasma-prone face. The clinical guidance on LED and melasma is not settled, and a responsible article will say that plainly rather than pick a side. What a practitioner can act on is the pattern: a photosensitive or pigment-prone client, a course of light sessions, and a new or darkening patch is a combination that deserves attention rather than reassurance.
Pregnancy adds a second layer of uncertainty, and it is worth being precise about what that means. Pregnancy is not a known contraindication for LED in the way it is for some other modalities. It is a period in which pigment changes are common on their own, which makes attribution almost impossible — the melasma might have appeared without the mask. That uncertainty is the point: when you cannot tell whether the device did it, the professional move is to suspend the exposure and document, not to continue because the device is considered harmless.
The third input is medication and product use. Photosensitizing drugs — certain antibiotics, isotretinoin and other retinoids, some diuretics, some antihypertensives, and a long list of others — change how skin responds to light. A client who started a new prescription since her last visit is a different client for the purposes of any light-based treatment, and the intake form is where that gets caught.
What a screening step looks like in practice
The practically useful version of this is a short screen that runs before every light session, not once at the start of a package. Four questions, asked out loud, recorded in the chart:
Pigmentation history. Existing melasma, prior post-inflammatory hyperpigmentation, recent darkening the client attributes to sun, pregnancy, or hormones. If pigment is already unstable, light is not the place to test it.
Photosensitizing medication or actives. New prescriptions since the last visit, isotretinoin, retinoids in the last week, and any professional peel scheduled in the same window.
Pregnancy, breastfeeding, and hormonal changes. Not because LED is prohibited, but because it changes the baseline and the client's tolerance for any unexpected reaction.
Current skin state. Barrier disruption, active rash, recent sunburn, or a fresh reaction to a product. Nothing gets layered on compromised skin, light included.
Two operational details make this survive contact with a busy day. The screen goes on the intake form so it is answered in writing before the room, and the answer gets re-checked if more than a few weeks have passed. And the consent conversation mentions pigment explicitly — not as a scare, but as the one thing to watch for, so the client knows what to report and when.
The treatment-room version of the protocol
For practitioners running LED as a finishing step, the questions the original post raises point at a protocol rather than at a device. A dome-based LED session is not the same as an at-home mask — the exposure geometry, the distance, and the session length are different, and the practitioner controls all three. That control is what makes the difference between an add-on that is easy to screen and one that is handed to a client by default.
The equipment side of this matters less than the framework, but it does matter. A platform such as the O2toDerm oxygen jet dome with LED light therapy is the kind of device that makes the screening decision explicit, because the LED step is a defined, timed segment of the session that the provider starts — not an ambient feature of the room. That distinction is what lets you say, honestly, that you skip the light on a given client and finish the facial another way. If the light cannot be left off without losing the treatment, the protocol is running you instead of the other way around, and the screening question will keep getting deferred.
Three protocol rules cover most of the situations this question comes up in. Skip the light on pigment-unstable skin, and note it in the chart with the reason. Keep at-home device use out of the first week of a professional course, so the two exposures are not stacked and unattributable. And when a client reports a new patch after any light exposure — professional or at-home — stop, document with an image, and refer. Pigment changes are one of the few things an esthetician cannot take back once it has developed, and the referral is not an admission that the treatment failed.
What the ten-year esthetician is really asking
The most useful line in the post is the aside about why she stopped: she ran out of time. The LED step was the part of the facial that got dropped when the schedule tightened, which is a fair indication of what it was contributing to her outcomes. That is not an argument against LED. It is an argument for deciding deliberately whether the modality is a treatment you prescribe with screening criteria and a documented plan, or a default finishing step that gets applied to everyone and dropped when the day runs late.
Those two options have different requirements. The second one needs no screening, because it is treated as decoration. The first needs the four questions above, a chart note, and the ability to say no to a client who has paid for the session. For a modality that most practitioners describe as safe, the discipline belongs on the front end — before the appointment, in writing, with the pigment question asked out loud. The alternative is what the post describes: a spot on your own forehead, and a professional rethinking ten years of practice in one week.